HOSHINO TATSUO has a total of 14 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2002. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are MICROBIOPHARM JAPAN CO LTD, ECOPIA BIOSCIENCES INC and CORLAY SL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | EPO (European Patent Office) | 1 | |
#3 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Fermentation | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Peptides | |
#6 | Heterocyclic compounds | |
#7 | Microorganisms | |
#8 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Hoshino Tatsuo | 14 |
#2 | Setoguchi Yutaka | 4 |
#3 | Shinjoh Masako | 4 |
#4 | Tomiyama Noribumi | 3 |
#5 | Ichikawa Keiko | 3 |
#6 | Tazoe Masaaki | 3 |
#7 | Tabata Kazuyuki | 2 |
#8 | Shimma Nobuo | 2 |
#9 | Ojima Kazuyuki | 2 |
#10 | Shimizu Sakayu | 2 |
Publication | Filing date | Title |
---|---|---|
EP3624849A1 | Combination therapy using ascochlorin derivative | |
US2009142815A1 | Vitamin C production in a microorganism, gluconobacter | |
US2006024796A1 | Transcriptional activator gene for genes involved in cobalamin biosynthesis | |
US2006121587A1 | Process for actinol production from ketoisophorone | |
US2006121586A1 | Process for producing phorenol |